262 related articles for article (PubMed ID: 30912213)
1. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
Hajjaji IM; Eshwihdi N; Barrowman N
Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan.
Hui E; Bravis V; Salih S; Hassanein M; Devendra D
Int J Clin Pract; 2010 Jul; 64(8):1095-9. PubMed ID: 20337752
[TBL] [Abstract][Full Text] [Related]
3. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
4. Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus.
Roach P; Arora V; Campaigne BN; Mattoo V; Rangwala S;
Diabetes Obes Metab; 2003 Sep; 5(5):311-6. PubMed ID: 12940868
[TBL] [Abstract][Full Text] [Related]
5. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial.
Watada H; Imori M; Li P; Iwamoto N
Endocr J; 2017 Jul; 64(7):705-717. PubMed ID: 28539526
[TBL] [Abstract][Full Text] [Related]
6. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes.
Jovanovič L; Peters AL; Jiang HH; Hardin DS
Aging Clin Exp Res; 2014 Apr; 26(2):115-21. PubMed ID: 24092662
[TBL] [Abstract][Full Text] [Related]
7. Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study.
Nishimura R; Tsujino D; Taki K; Morimoto A; Tajima N
Cardiovasc Diabetol; 2010 May; 9():16. PubMed ID: 20438630
[TBL] [Abstract][Full Text] [Related]
8. Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.
Hassanein M; Echtay AS; Malek R; Omar M; Shaikh SS; Ekelund M; Kaplan K; Kamaruddin NA
Diabetes Res Clin Pract; 2018 Jan; 135():218-226. PubMed ID: 29183844
[TBL] [Abstract][Full Text] [Related]
9. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.
Christiansen JS; Vaz JA; Metelko Z; Bogoev M; Dedov I
Diabetes Obes Metab; 2003 Nov; 5(6):446-54. PubMed ID: 14617231
[TBL] [Abstract][Full Text] [Related]
10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
11. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
[TBL] [Abstract][Full Text] [Related]
12. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.
Mattoo V; Milicevic Z; Malone JK; Schwarzenhofer M; Ekangaki A; Levitt LK; Liong LH; Rais N; Tounsi H;
Diabetes Res Clin Pract; 2003 Feb; 59(2):137-43. PubMed ID: 12560163
[TBL] [Abstract][Full Text] [Related]
13. Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin.
Herz M; Arora V; Sun B; Ferguson SC; Bolli GB; Frier BM
Diabet Med; 2002 Nov; 19(11):917-23. PubMed ID: 12421428
[TBL] [Abstract][Full Text] [Related]
14. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
[TBL] [Abstract][Full Text] [Related]
15. Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group.
Akram J; De Verga V
Diabet Med; 1999 Oct; 16(10):861-6. PubMed ID: 10547214
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T
Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837
[TBL] [Abstract][Full Text] [Related]
17. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
Kobeissy A; Zantout MS; Azar ST
Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
[TBL] [Abstract][Full Text] [Related]
18. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.
Sakharova OV; Lleva RR; Dziura JD; Spollett GR; Howell SK; Beisswenger PJ; Inzucchi SE
J Diabetes Complications; 2012; 26(4):333-8. PubMed ID: 22541894
[TBL] [Abstract][Full Text] [Related]
19. Switching from biphasic human insulin to biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN subgroup of the A₁chieve study.
Hussein Z; Lim-Abrahan MA; Jain AB; Goh SY; Soewondo P
Diabetes Res Clin Pract; 2013 Apr; 100 Suppl 1():S24-9. PubMed ID: 23647714
[TBL] [Abstract][Full Text] [Related]
20. Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.
Altuntas Y; Ozen B; Ozturk B; Sengul A; Ucak S; Ersoy O; Karul S
Diabetes Obes Metab; 2003 Nov; 5(6):371-8. PubMed ID: 14617222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
